A single-arm phase 2 study of talimogene laherparepvec in patients with lower-risk invasive cutaneous squamous cell cancer

Delaney Stratton(University of Arizona), Clara Curiel‐Lewandrowski(University of Arizona), Denise J. Roe(University of Arizona), Haiyan Cui(Tongji University), S Sundararajan(Hanby Environmental (United States))
Journal of the American Academy of Dermatology
November 17, 2025
Cited by 0


Related Papers